Evaluation of chronic toxicity and carcinogenicity of ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate in Sprague-Dawley rats

Toxicology Reports

Volumn 2, Issue , 2015, Pages 939-949

  Rae, Jessica M Caverly ^a   Craig, Lisa ^b   Slone, Theodore W ^b   Frame, Steven R ^a   Buxton, L William ^a   Kennedy, Gerald L ^a  

^a DUPONT COMPANY   (United States)

^b MPI RESEARCH   (United States)

Author keywords

Chronic toxicity and carcinogenicity study; Fluoropolymers; PPAR agonist; Sprague Dawley rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMMONIUM 2,3,3,3 TETRAFLUORO 2 (HEPTAFLUOROPROPOXY) PROPANOATE; GAMMA GLUTAMYLTRANSFERASE; IDITOL DEHYDROGENASE; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BODY WEIGHT; CARCINOGENICITY; CELL HYPERPLASIA; CHRONIC TOXICITY; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HEMATOCRIT; HEMATOLOGY; HISTOLOGY; LIVER INJURY; MALE; NONHUMAN; PATHOLOGY; RAT; URINALYSIS;

EID: 84933530252     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2015.06.001     Document Type: Article

References (29)

1. Agresti A. Categorical Data Analysis 2002, John Wiley and Sons, New York. 2nd ed.
2. Allison P.D. Survival Analysis Using the Sas System: A Practical Guide. Cary (NC) 1995, SAS Institute Inc.
3. Biegel L.B., Hurtt M.E., Frame S.R., Applegate M., Conner J.C., Cook J.C. Comparison of the effects of Wyeth-14643 in Crl:CD BR and fisher rats. Fundam. Appl. Toxicol. 1992, 19:590-597.
4. Biegel L.B., Hurtt M.E., Frame S.R., O'Connor J.C., Cook J.C. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male rats. Toxicol. Sci. 2001, 60:44-55.
5. Butenhoff J.L., Kennedy G.L., Chang S.-C., Olson G.W. Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague-Dawley rats. Toxicology 2012, 298:1-13.
6. Cook J.C., Klinefelter G.R., Hardisty J.F., Sharpe R.M., Foster P.M. Rodent leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms and relevance to humans. Crit. Rev. Toxicol. 1999, 29:169-261.
7. Cunningham M.L., Collins B.J., Hejtmancik M.R., Herbert R.A., Travlos G.S., Vallant M.K., Stout M.D. Effects of the PPARα agonist and widely used antihyperlipidemic drug gemfibrozil on hepatic toxicity and lipid metabolism. PPAR Res. 2010, 963. (Article no. 681).
8. Gervois P., Kleemann R., Pilon A., Percevault F., Koenig W., Staels B., Kooistra T. Global suppression of IL-6 induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-α activator fenofibrate. J. Biol. Chem. 2004, 279(16):16154-16160.
9. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 1955, 50:1096-1121.
10. Du Pont de Nemours (Nederland) B.V. (2014). EU REACH Registration, Ammonium 2,3,3,3-Tetrafluoro-2-(Heptafluoropropoxy) Propanoate. Available from: http://apps.echa.europa.eu/registered/data/dossiers/DISS-a1335ad2-51da-54b5-e044-00144f67d031/DISS-a1335ad2-51da-54b5-e044-00144f67d031_DISS-a1335ad2-51da-54b5-e044-00144f67d031.html.
11. Gannon S.A., Fasano W.J., Mawn M.P., Nabb D.L., Buck R.C., Buxton L.W., Jepson G.W., Frame S.R. Absorption, Distribution, Metabolism and Excretion of 2,3,3,3-Tetrafluoro-2-(Heptafluoropropoxy) Proprionic Acid Ammonium Salt in Rat, Mouse, and Cynomolgus Monkey 2015, (in preparation).
12. Haas M.C. A 28-day Oral (Gavage) Toxicity Study of H-28397 in Rats with a 28-day Recovery (Study No. Wil-189205) 2008, WIL Research Laboratories, LLC, Ashland, OH.
13. Haas M.C. A 90-day Oral (Gavage) Toxicity Study of H-28548 in Rats with a 28-day Recovery (Study No. Wil-189216) 2009, WIL Research Laboratories, LLC, Ashland, OH.
14. Hertz R., Seckbach M., Zakin M.M., Bar-Tana J. Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators. J. Biol. Chem. 1996, 271(1):218-224.
15. Huang H.-L., Shaw N.-S. Role of hypolipidemic drug clofibrate in altering iron regulatory proteins IRP1 and IRP2 activities and hepatic iron metabolism in rats fed a low-iron diet. Toxicol. Appl. Pharmacol. 2002, 180:118-128.
16. Klaunig J.E., Babich M.A., Baetcke K.P., Cook J.C., Corton J.C., David R.M., DeLuca J.G., Lai D.Y., McKee R.H., Peters J.M., Roberts R.A., Fenner-Crisp P.A. PPARα agonist-induced rodent tumors: modes of action and human relevance. Crit. Rev. Toxicol. 2003, 33:655-780.
17. Klaunig J.E., Hocevar B.A., Kamendulis L.M. Mode of action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and human relevance. Reprod. Toxicol. 2012, 33(4):410-418.
18. Klaunig J.E., Shinghara M., Iwai H., Chengelis C.P., Kirkpatrick J.B., Wang Z., Bruner R.H. Evaluation of the chronic toxicity and carcinogenicity of perfluorohexanoic acid (PFHxA) in sprague-dawley rats. Toxicol. Pathol. 2014, (published online 28.05.14). 10.1177/0192623314530532.
19. Malley L.A., Carakostas M., Hansen J.F., Rusch G.M., Kelly D.P., Trochimowicz H.J. Two-year inhalation toxicity study in rats with hydrochlorofluorocarbon 123. Fundam. Appl. Toxicol. 1995, 25:101-114.
20. Milliken G.A., Johnson D.E. Analysis of Messy Data 1992, Chapman and Hall, London.
21. MPI, Research Neoplastic Historical Control Data, Male and Female Sprague-Dawley Rat - Charles River Laboratories, 2 Year Studies, Version 4.0, August 2001-August 2011.
22. MPI, Research Non-neoplastic Historical Control Data, Male and Female Sprague-Dawley rat - Charles River Laboratories, 2 Year Studies, Version 4.0, June 2002-October 2010.
23. Peters J.M., Cheung C., Gonzales F.J. Peroxisome-proliferator-activated receptor-alpha and liver cancer: where do we stand?. J. Mol. Med. 2005, 83:774-785.
24. Peto R., Pike M.C., Day N.E., Gray R.G., Lee P.N., Parish S., Pete J., Richards S., Wahrendorf J. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. Long-Term and Short-Term Screening Assays for Carcinogens: A Critical Appraisal. Annex to Supplement 2 1980, 311-426. International Agency for Research on Cancer, Lyon.
25. Prentice D.E., Meikle A.W. A review of drug-induced leydig cell hyperplasia and neoplasia in the rat and some comparisons with man. Hum. Exp. Toxicol. 1995, 14:562-572.
26. Svoboda D.J., Azarnoff D.L. Tumors in male rats fed ethylchlorophenoxyisobutyrate, a hypolipidemic drug. Cancer Res. 1979, 39:3419-3428.
27. P.J. Thomford, 104- Week Dietary Chronic Toxicity and Carcinogenicity Study with Perfluorooctane Sulfonic Acid Potassium Sale (PFOS; T-6295) in Rats. Final Report, 3M T-6295 (Covance Study No. 6329-183, vol. I-IX, 4068 pgs, 3M, St. Paul, MN, 2002.
28. Welch B.L. The significance of difference between two means when the population variances are unequal. Biometrika 1937, 29:350-362.
29. Zar J.H. Biostatistical Analysis 1999, Prentice Hall, New Jersey. 4th ed.